COMPOSES ET COMPOSITIONS POUR LE TRAITEMENT DE TUMEURS EXPRIMANT EGFR
- 专利权人:
- INC.;SHANGHAI BIRDIE BIOTECH
- 发明人:
- LI, LIXIN
- 申请号：
- CA2936377
- 公开号：
- CA2936377A1
- 申请日:
- 2015.01.08
- 申请国别(地区):
- CA
- 年份:
- 2015
- 代理人:
- 摘要：
- Provided are compounds for targeted immunotherapy. The compounds are useful in the treatment of EGFR expressing tumors/cancers. Also provided are compositions comprising the compounds.
- 来源网站：
- 中国工程科技知识中心
相关发明人
相关专利
- COMPOSÉS ET COMPOSITIONS POUR LE TRAITEMENT DE TUMEURS EXPRIMANT EGFR
- PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND GM3 N- GLYCOLYL GANGLIOSIDE (NeuGcGM3)
- EGFR N- GM3 NEUGCGM3 Pharmaceutical compositions for the treatment of tumors that express EGFR and ganglioside N-glycolyl GM3 NEUGCGM3
- PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF TUMORS EXPRESSING EGFR AND N-GLYCOLYL LIANGLYOSIDE GM3 (NEUGcGM3)
- Pharmaceutical compositions for the treatment of tumors expressing EGFR and GM3 N-glycolyl ganglioside (NeuGcGM3)
